These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors. Randolph JT, Huang PP, Flosi WJ, DeGoey D, Klein LL, Yeung CM, Flentge C, Sun M, Zhao C, Dekhtyar T, Mo H, Colletti L, Kati W, Marsh KC, Molla A, Kempf DJ. Bioorg Med Chem; 2006 Jun 15; 14(12):4035-46. PubMed ID: 16504523 [Abstract] [Full Text] [Related]
6. Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacer. Stranix BR, Sauvé G, Bouzide A, Coté A, Sévigny G, Yelle J. Bioorg Med Chem Lett; 2003 Dec 15; 13(24):4289-92. PubMed ID: 14643311 [Abstract] [Full Text] [Related]
8. Oximinoarylsulfonamides as potent HIV protease inhibitors. Yeung CM, Klein LL, Flentge CA, Randolph JT, Zhao C, Sun M, Dekhtyar T, Stoll VS, Kempf DJ. Bioorg Med Chem Lett; 2005 May 02; 15(9):2275-8. PubMed ID: 15837308 [Abstract] [Full Text] [Related]
14. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies. Bouzide A, Sauvé G, Yelle J. Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1509-13. PubMed ID: 15713418 [Abstract] [Full Text] [Related]
15. Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385. Miller JF, Andrews CW, Brieger M, Furfine ES, Hale MR, Hanlon MH, Hazen RJ, Kaldor I, McLean EW, Reynolds D, Sammond DM, Spaltenstein A, Tung R, Turner EM, Xu RX, Sherrill RG. Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1788-94. PubMed ID: 16458505 [Abstract] [Full Text] [Related]
16. Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors. Huang PP, Randolph JT, Klein LL, Vasavanonda S, Dekhtyar T, Stoll VS, Kempf DJ. Bioorg Med Chem Lett; 2004 Aug 02; 14(15):4075-8. PubMed ID: 15225729 [Abstract] [Full Text] [Related]